Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-059455
Filing Date
2026-05-12
Accepted
2026-05-12 16:34:51
Documents
108
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vreof-20260331x10q.htm   iXBRL 10-Q 1723459
2 EX-10.3 vreof-20260331xex10d3.htm EX-10.3 132490
3 EX-31.1 vreof-20260331xex31d1.htm EX-31.1 12084
4 EX-31.2 vreof-20260331xex31d2.htm EX-31.2 11763
5 EX-32.1 vreof-20260331xex32d1.htm EX-32.1 8858
  Complete submission text file 0001104659-26-059455.txt   10009176

Data Files

Seq Description Document Type Size
6 EX-101.SCH vreof-20260331.xsd EX-101.SCH 92882
7 EX-101.CAL vreof-20260331_cal.xml EX-101.CAL 95356
8 EX-101.DEF vreof-20260331_def.xml EX-101.DEF 368408
9 EX-101.LAB vreof-20260331_lab.xml EX-101.LAB 710221
10 EX-101.PRE vreof-20260331_pre.xml EX-101.PRE 565996
112 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20260331x10q_htm.xml XML 1773091
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 26969219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)